ArticleFrontiers in nutrition2025
A comprehensive analysis of vitamin a deficiency burden and trends: insights from the global burden of disease study 2021 and future predictions to 2050.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitamin A deficiency (VAD) continues to pose a significant public health challenge, particularly in low socio-demographic index (SDI) regions, contributing to increased infections, blindness, and child mortality. Its causes include poor diets, absorption issues, and infectious diseases. Objective: To comprehensively assess the global trends and burden of Vitamin A Deficiency from 1990 to 2021 and to forecast the global VAD-related burden from 2022 to 2050. Methods: This investigation employed data from the GBD 2021 database to analyze the global burden of nutritional deficiencies attributable to VAD. Disability-adjusted life-years (DALYs) and years lived with disability (YLDs) were systematically evaluated by gender, age groups, geographic regions, and countries over the 32-year study period (1990-2021). Temporal trends in age-standardized DALYs rate (ASDR) and age-standardized YLDs rate (ASYR) were quantified using estimated annual percentage change (EAPC) analysis. Projections of future burden were generated using exponential smoothing (ES) and autoregressive integrated moving average (ARIMA) models. Results: In 2021, the global burden of VAD was 1,104,931 DALYs, down from 1,970,337 in 1990. The ASDR dropped from 32.56 in 1990 to 15.73 in 2021, with an EAPC of -2.81%. Males had higher ASDR than females, both showing significant declines. The greatest burden was in the <5-year-old age group. An inverse SDI-ASDR associations was evident, with high-SDI regions achieving the fastest rate reductions. Projections to 2050 using ARIMA and ES models predicted a continued decrease in DALYs, with faster declines in males, although the ES model suggested a stabilization in DALYs for both genders. Conclusion: The GBD 2021 data underscored the persistent global challenge of addressing VAD. Solving this issue necessitates comprehensive strategies that combine targeted interventions, policy reforms, and collaborative efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.